Divergence with 52wk Highs signaling a bottomLast Friday was counted as a follow through day, but that could be easily erased. More now with what happened this weekend in Israel.
The follow through day is a good leading signal and the 52wk Highs is a more complete one as is giving hints about the health of the whole market.
Still the 52wk Lows is still above, lets wait for confirmation.
52weeklows
RIVN - Weekly Supply rejection 👀📉NASDAQ:RIVN
Daily printed shooting star on high volume after rejecting weekly supply zone. Also rejected high volume node. Massive volume gap below. Expecting a huge sell off as long as stays below 28 level targeting 16/15 support zone.
LOWEST CLOSE SINCE 10 NOV 2020 🤯NYSE:BAC
Lowest daily in over 3 years and a massive open gap below. Huge weekly uptrend breakdown.
Expecting another -10% downside from current levels to fill the gap. There are very high chances that bank of america revisits COVID lows.
Sasol 52 week lowJSE:SOL has printed a new 52 week low. R248-ish is still possible if the stock continue to weaken. No position.
COIN-New 52 Week Low!COIN recently made a new 52 week low!
A descending triangle pattern was identified on the daily chart. Price broke below the lower trendline of the pattern.
Also, a falling wedge pattern was identified on the one hour chart. COIN traded in a tight range Friday and closed in the supply zone .
MrALtrades00
New 52 Week lows for BTC in playLook's like BTC is forming a Bear Flag and a possible breakdown might target new lower prices.
Price Target #1: $14,500
Price Target #2: $13,500
As always thanks for your follows, likes, and comments. Let’s learn and grow together. Cheers!
*This information and publication is not meant to be, and do not constitute, financial, investment, trading, or other types of advice. Do your own research.
NQ Futures 22-12 15 HTF BreakOut Idea out of Sideways PAOn the weekly we have a high of last week if we break out above that on the current weekly period looking to continue up w a target of breakout above $11333 as a point to pivot or break down if there is a stall at or above the level.
On the weekly we have seen a lot of stocks hit 52 week lows continuing there can be more of that if we do we expect a move down in NQ to below last weeks low prices and make a new low which will be a new 52(+) low on NQ futures and will likely in that case take along QQQ's into new 52 week lows.
Nampak ending the week below R2/shareFundamentals aside, there was a time where JSE:NPK had promising technicals. Bought the stock and it failed to move up, after months of waiting I had to pull the cord. With the benefit of hindsight, that was a good thing to do. The stock is closing the week below R2/share and on the list of 52 week low stocks.
LTCUSDT - SETUPLTCUSDT's price has just hit the long-term support zone. Previously every time bulls come forward and take the charge. But this support is getting weaker after so many attempts. So we optimistically expect that there will be a bounce up to 130.0 followed by a 140.0 level as RSI is in the oversold region.
$RIOT reaching December 2020 levelSince the turn of the year, everything has been dropping heavily in the wake of inflation, rates and worries of WWIII. RIOT reached levels it has not seen since late 2020.
Comparing to BTC price.
52-Weeks Low Made for #BABA#BABA has been trading under Bear Pressure for so many months and weeks and this week it has made a new 52-Weeks Low which is a strong Sell as per Technical Analysis. As it is visible on charts, our Fast Moving Momentum indicating further weakness and a possibility of making another Low from here. As it is trading near its support level, this may get some buying interest and may bounce from here for a shorter period of time or this may fall further from here without a dead cat bounce from here.
In both situations, Sell either when the current Low is broken or it rises upto 170-180 and short between this range with SL as 180.
Disclaimer :
Trading is never ever recommended as it is injurious to mankind. This is purely my study based on technical charts and for educational purpose only. Please do your analysis before taking any trades given by me. I MUST not be held responsible for any profit or loss out of any trades you take on our advice. All Disclaimers Apply.
MTLS- Leading 3D printing & additive manufacturing playerPure swing/intermediate play without taking much fundamentals into the consideration so set the tight stop loss accordingly. Just my two cents. Please do your own research.
SLNO - Extreme Oversold Territory Going Long...SLNO - took a dive when the FDA demanded more testing of their latest drug. They are working on that and I suspect that we will see a retrace to 2.32 and possible sideways consolidation as the bulls sheepishly return to this little gem. I'm gonna run towards this as the bulls are running away. Be greedy when everyone else is afraid (Warren Buffet's play book) I'm going long! Price target of 2.32.
BUY $VIVE VIVEVE MEDICAL STOCK ASAP $3.60Premarket Opened at $3.60 for an insane alltime Low! This is the vulture trade, buy what everyone thinks is dead and sell it once they want it at a higher price!
I highlight a falling bullish wedge triangle for a strong reversal towards $20.
CNN Money Predicts 20.00
This is a strong hold! Strong buying opportunity!
Long Term Call, Huge Demand Zone, Buy on every dip BOB is at 2009 lows and is in a strong demand zone. Buy on every dip or else you can wait for the right moment to enter, just keep and eye on it.
BUY First Solar Now (~$50)Big future awaits solar energy, so everyone understands this and therefore investors won't give up on this stock.
Long-term growth perspective is huge.
Thus, you can buy the stock now at it's lows and hold it untill the good times.Don't track it everyday, save your nerves. FSLR may at least double it's current price.
But you can take advantage of the future growth in short term trade:
Buy @ +-$50
Short stop @ $49
Take @ ~$59
Be aware, that there is a high probability to trigger your stop due to the coronavirus fears and economic or polytic impact, but still it worth it.
Have a good luck!
Can TTNP Actually Gap Fill Or Is It Forever Going To Trade Here?TTNP has been catching attention on volume scans this month. Ever since gapping down on October 16, the daily action is noticeably greater than before. But is this a good or bad sign for the penny stock? Currently trading around $0.20. OS is around 17 million so it's not the biggest out there but not the smallest either.
Titan Pharmaceuticals is a company that develops treatments for chronic diseases using its ProNeura platform. Titan announced a $9 million public offering a week ago. While the company’s stock took a price hit due to the per-share pricing of the offering it is okay.It is okay because ever since the company did this, a surge of volume has entered the stock. In addition to this, analysts are taking notice of the company too. Maxim Group upgraded TTNP stock from “HOLD” to “BUY” this week and gave a $1 price target.
ABOUT TTNP
Titan Pharmaceuticals Inc is a specialty pharmaceutical company. It is engaged in the development of pharmaceutical products. Its product pipeline consists of Probuphine for Opioid addiction, Ropinirole for Parkinson's disease, Triiodothyronine (T3) for hypothyroidism. It generates revenue principally from collaborative research and development arrangements, technology licenses, and government grants.
QUOTE SOURCE: 4 Penny Stocks Catching Biotech Investors By Surprise
AAL at multi year lowswheres the bounce? needs to bounce here or its going to get ugly... airlines across the board are green on 8/26 but this cant get out of its own way. interesting to see it hit it head on the 20 day average quite a bit. still holding and averaged down on 9/13 calls.. GL
MIK bullish divergence Nothing too crazy here, just NASDAQ:MIK making a fresh new 52wk low while showing some bullish divergence. For study purposes i would be long this stock for a short bounce. lets see where it goes
Everything here is purely my opinion, and in no way advice or recommendations on making trades. I may or may not hold positions in the instruments I analyze.
Cheers,
Les
2nd Trade: Zumtobel and the 52 Week StrategyThe second trade in the £800 to £1 million challenge is a short on Vienna Exchange Stock Zumtobel. In my first post, i highlighted that during the challenge i will be using Put Options to go Short. There are 2 reasons for this. Firstly i love Options Trading and secondly i feel more comfortable with a maximum loss. Buying a Put Option allows me to firstly reduce my cost exposure and going into the trade i know i can only lose the cost of the option premium.
Why did i chose Zumtobel to short?
Trading strategy 1 (Name: B52) highlighted that the stock was in the danger zone. This strategy effectively looks at where in the cycle a stock is at and calculates the percentage distance from either its 52 week high or low. In the case of Zumtobel, the system came back with screaming shorts.
To confirm the trade i overlayed Trading Strategy 2 (Name: AlphaR). Based on linear regression, the strategy highlights break points and pressure zones. In the case of Zumtobel, the pressure zone highlighted further downside risk.
Trade Details
04/07/2018 11:21 04/07/2018 Buy 3 ZAG P4.80 21DEC18@0.3 EUR (DE000C2GV9J8) ZAG P4.80 21DEC18 EUR -90.00
In summary for a cost (premium) of 30c (EUR 90), i have exposure to 300 shares on the downside. I did buy out of the money puts at the time, however gave myself enough time (Dec expiry) for the stock to reach the target. I believe the stock will go to $3.50.
RENN Chart Discrepancy Large gap to fill to $6. Lots of people shorted based of this charts price action finviz.com but as I look further I find this is inaccurate. If this breaks $3.20 again it has no previous resistance till $6 and the RSI is very oversold sellers look to be exhausted.
endp - long endp broke 52 week low on high volume but as of yesterday ENDP announced that the FDA Drug Safety Risk Management and Anesthetic and Analgesic Drug Products Advisory Committees had voted in the ratio of 18 to eight and consented that the benefits of reformulated Opana ER (oxymorphone hydrochloride extended release) no longer outweigh its risks. Which could be seen as good news for investors since the drugs wont be taken off market although there is still tough generic competition
